OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Vaccine (2022) Vol. 40, Iss. 12, pp. 1761-1767
Open Access | Times Cited: 15
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, et al.
Vaccine (2022) Vol. 40, Iss. 12, pp. 1761-1767
Open Access | Times Cited: 15
Showing 15 citing articles:
Immunogenicity and Safety of Homologous and Heterologous Prime–Boost Immunization with COVID-19 Vaccine: Systematic Review and Meta-Analysis
Haoyue Cheng, Zhicheng Peng, Shuting Si, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 798-798
Open Access | Times Cited: 31
Haoyue Cheng, Zhicheng Peng, Shuting Si, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 798-798
Open Access | Times Cited: 31
Clinical perspective on topical vaccination strategies
Petya Popova, Sunny P. Chen, Suiyang Liao, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115292-115292
Open Access | Times Cited: 7
Petya Popova, Sunny P. Chen, Suiyang Liao, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115292-115292
Open Access | Times Cited: 7
Safety and immunogenicity of Ad5-nCoV administered intradermally by needle-free injector in rats
Li Chen, Xiaoyin Zhang, Lairun Jin, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Li Chen, Xiaoyin Zhang, Lairun Jin, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
Sira Nanthapisal, Thanyawee Puthanakit, Peera Jaru-Ampornpan, et al.
Vaccine (2022) Vol. 40, Iss. 18, pp. 2551-2560
Open Access | Times Cited: 14
Sira Nanthapisal, Thanyawee Puthanakit, Peera Jaru-Ampornpan, et al.
Vaccine (2022) Vol. 40, Iss. 18, pp. 2551-2560
Open Access | Times Cited: 14
Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose
Geert V.T. Roozen, Manon L. M. Prins, Corine Prins, et al.
Clinical Microbiology and Infection (2024)
Open Access | Times Cited: 2
Geert V.T. Roozen, Manon L. M. Prins, Corine Prins, et al.
Clinical Microbiology and Infection (2024)
Open Access | Times Cited: 2
Evaluation of the Safety and Immunogenicity of Fractional Intradermal COVID-19 Vaccines as a Booster: A Pilot Study
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Zheng Quan Toh, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1497-1497
Open Access | Times Cited: 11
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Zheng Quan Toh, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1497-1497
Open Access | Times Cited: 11
Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
Lairun Jin, Rong Tang, Shipo Wu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Lairun Jin, Rong Tang, Shipo Wu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine
Ratchanon Sophonmanee, Jomkwan Ongarj, Bunya Seeyankem, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1494-1494
Open Access | Times Cited: 9
Ratchanon Sophonmanee, Jomkwan Ongarj, Bunya Seeyankem, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1494-1494
Open Access | Times Cited: 9
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccination
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Immunogenicity of Intradermal Versus Intramuscular BNT162b2 COVID-19 Booster Vaccine in Patients with Immune-Mediated Dermatologic Diseases: A Non-Inferiority Randomized Controlled Trial
Chutima Seree-aphinan, Ploysyne Rattanakaemakorn, Poonkiat Suchonwanit, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 73-73
Open Access | Times Cited: 1
Chutima Seree-aphinan, Ploysyne Rattanakaemakorn, Poonkiat Suchonwanit, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 73-73
Open Access | Times Cited: 1
Evaluation of the safety and immunogenicity of fractional intradermal COVID-19 vaccines as a booster: A pilot study
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Zheng Quan Toh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Suvimol Niyomnaitham, Somruedee Chatsiricharoenkul, Zheng Quan Toh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Relative vaccine effectiveness of ChAdOx1/AZD1222 vaccines as booster dose via intradermal injection with a one-fifth dose compared with the intramuscular injection in the prevention of SAR-CoV-2 infections in Phuket – A Retrospective Cohort Study
Withita Jangiam, Kusuma Swangpun, Sopon Iamsirithaworn, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107179-107179
Closed Access
Withita Jangiam, Kusuma Swangpun, Sopon Iamsirithaworn, et al.
International Journal of Infectious Diseases (2024) Vol. 147, pp. 107179-107179
Closed Access
Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
Sue Ann Costa Clemens, Natalie G. Marchevsky, Sarah Kelly, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 1
Sue Ann Costa Clemens, Natalie G. Marchevsky, Sarah Kelly, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 1
Optimal control strategy for the administration of the third vaccine dose in the treatment of pandemic COVID-19
I. Khaloufi, Youssef Benfatah, Marouane Lafif, et al.
Mathematical Modeling and Computing (2023) Vol. 10, Iss. 3, pp. 841-853
Open Access | Times Cited: 1
I. Khaloufi, Youssef Benfatah, Marouane Lafif, et al.
Mathematical Modeling and Computing (2023) Vol. 10, Iss. 3, pp. 841-853
Open Access | Times Cited: 1
Safety and Immunogenicity of Intradermal Administration of Fractional Dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as Primary Series Vaccination
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Somruedee Chatsiricharoenkul, Suvimol Niyomnaitham, Harry Joshua Posen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
